CLINICAL_TRIALS
research
· 2026-04-01
Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) [Phase 3]
Summary
A Phase 3 randomized trial is evaluating Azetukalner versus placebo for depressive episodes in bipolar disorder (bipolar I or II); the study is currently recrui…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Bipolar Disorder, Bipolar Depression | Phase 3 | Status: RECRUITING